Enhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicines

被引:469
|
作者
Greish, Khaled [1 ]
机构
[1] Sojo Univ, Fac Pharmaceut Sci, Lab Microbiol & Oncol, Kumamoto 8600082, Japan
基金
日本学术振兴会;
关键词
EPR effect; nanomedicines; micelles; targeted anticancer therapy; macromolecular drugs;
D O I
10.1080/10611860701539584
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Over the past two decades cancer has ascended the causes of human death to be number one or two in many nations world wide. A major limitation inherent to most conventional anticancer chemotherapeutic agents is their lack of tumor selectivity. One way to achieve selective drug targeting to solid tumors is to exploit abnormalities of tumor vasculature, namely, hypervascularisation; aberrant vascular architecture; extensive production of vascular permeability factors stimulating extravasation within tumor tissues, and lack of lymphatic drainage. Maeda and his colleagues have extensively studied tumor vascular abnormalities in terms of active and selective delivery of anticancer drugs to tumor tissues, notably defining the enhanced permeability and retention effect (EPR effect) of macromolecular drugs in solid tumors. Due to their large molecular size, nanosized macromolecular anticancer drugs administered intravenously (i.v.) escape renal clearance. Often they can not penetrate the tight enclothelial junctions of normal blood vessels, but they can extravasate in tumour vasculature and become trapped in the tumor vicinity. With time the tumor concentration will build up reaching several folds higher than that of the plasma due to lack of efficient lymphatic drainage in solid tumor; an ideal application for EPR-based selective anticancer drug delivery. Establishing this principle hastened development of various polymer conjugates and polymeric micelles as well as multifunctional nanoparticles for targeted cancer chemotherapy. Indeed this selective high local concentration of nanosized anticancer drugs in tumor tissues has proven superior in therapeutic effect with minimal side effects in both preclinical and clinical settings. In this review the mechanisms and factors involved in the EPR effect, as well as the uniqueness of nanoscale drugs for tumor targeting through EPR effect, will be discussed in detail.
引用
收藏
页码:457 / 464
页数:8
相关论文
共 50 条
  • [21] Exploiting hypoxia in solid tumors with DNA-targeted bioreductive drugs
    Papadopoulou, MV
    Bloomer, WD
    DRUGS OF THE FUTURE, 2004, 29 (08) : 807 - 819
  • [22] Penetration of anticancer drugs through solid tissue: A factor that limits the effectiveness of chemotherapy for solid tumors
    Tunggal, JK
    Cowan, DSM
    Shaikh, H
    Tannock, IF
    CLINICAL CANCER RESEARCH, 1999, 5 (06) : 1583 - 1586
  • [23] CLINICAL EVALUATION OF COMBINATION CHEMOTHERAPY OF SOLID TUMORS WITH 5 OR 6 ANTICANCER DRUGS
    SAITO, T
    OHIRA, S
    WAKUI, A
    YOKOYAMA, M
    TAKAHASHI, H
    HIMORI, T
    ASAMURA, M
    KOBAYASHI, Y
    KANAMARU, R
    KIKKAWA, JI
    SUGAHARA, K
    KYO, KE
    KUDO, T
    MAEZAWA, S
    UJIIE, S
    KASUGAI, T
    HAYASHI, Y
    KATO, A
    SUGAWARA, N
    ICHIKAWA, T
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1969, 99 (04): : 331 - 346
  • [24] Noninvasive measurements for studying the tumoral pharmacokinetics of platinum anticancer drugs in solid tumors
    Dowell, JA
    Sancho, AR
    Anand, D
    Wolf, W
    ADVANCED DRUG DELIVERY REVIEWS, 2000, 41 (01) : 111 - 126
  • [25] Enhanced permeability and retention effect: A key facilitator for solid tumor targeting by nanoparticles
    Shinde, Vinod Ravasaheb
    Revi, Neeraja
    Murugappan, Sivasubramanian
    Singh, Surya Prakash
    Rengan, Aravind Kumar
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2022, 39
  • [26] Brain targeted delivery of anticancer drugs: prospective approach using solid lipid nanoparticles
    Anand, Anupriya
    Sugumaran, Abimanyu
    Narayanasamy, Damodharan
    IET NANOBIOTECHNOLOGY, 2019, 13 (04) : 353 - 362
  • [27] Simulation of transport and extravasation of nanoparticles in tumors which exhibit enhanced permeability and retention effect
    Podduturi, Vishwa Priya
    Magana, Isidro B.
    O'Neala, D. Patrick
    Derosa, Pedro A.
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2013, 112 (01) : 58 - 68
  • [28] Super enhanced permeability and retention (SUPR) effects in tumors following near infrared photoimmunotherapy
    Kobayashi, Hisataka
    Choyke, Peter L.
    NANOSCALE, 2016, 8 (25) : 12504 - 12509
  • [29] Clinical Actionability Enhanced through Deep Targeted Sequencing of Solid Tumors
    Chen, Ken
    Meric-Bernstam, Funda
    Zhao, Hao
    Zhang, Qingxiu
    Ezzeddine, Nader
    Tang, Lin-ya
    Qi, Yuan
    Mao, Yong
    Chen, Tenghui
    Chong, Zechen
    Zhou, Wanding
    Zheng, Xiaofeng
    Johnson, Amber
    Aldape, Kenneth D.
    Routbort, Mark J.
    Luthra, Rajyalakshmi
    Kopetz, Scott
    Davies, Michael A.
    de Groot, John
    Moulder, Stacy
    Vinod, Ravi
    Farhangfar, Carol J.
    Shaw, Kenna Mills
    Mendelsohn, John
    Mills, Gordon B.
    Eterovic, Agda Karina
    CLINICAL CHEMISTRY, 2015, 61 (03) : 544 - 553
  • [30] Polymer donors of nitric oxide for enhanced accumulation of anticancer agents in solid tumors
    Studenovsky, Martin
    Sirova, Milada
    Etrych, Tomas
    JOURNAL OF CONTROLLED RELEASE, 2017, 259 : E91 - E91